Synergistic activation of non-rectifying small-conductance chloride channels by forskolin and phorbol esters in cell-attached patches of the human colon carcinoma cell line HT-29cl.19A.
Cell-attached patch-clamp studies with the human colon carcinoma HT-29cl.19A cells revealed a small chloride channel with a unitary conductance of 6.5 pS at 70 mV and 4.6 pS at -70 mV clamp potential after cAMP was increased by activation of adenylyl cyclase by forskolin. Usually channels inactivated upon patch excision, but in a few excised patches the channels stayed active and displayed a linear I/V relation in symmetrical (150 mmol/l) chloride solutions with a conductance of 7.5 pS. A 16-fold increase in channel incidence was observed when forskolin and phorbol 12,13-dibutyrate (PDB) were present together. The open probability was voltage-independent and was not different in the presence of forskolin plus PDB or with forskolin alone. The conductance sequence of the channel as deduced from outward currents carried by five different anions including chloride was: Cl- > BR- > NO3- > gluconate > I-. The permeability sequence deduced from the reversal potentials was NO3- > or = Br- > Cl- > I- > gluconate. With iodide in the pipette the conductance decreased strongly. Moreover, the inward current was reduced by 61%, indicating a strong inhibition of the chloride efflux by iodide. Similarly, the forskolin-induced increase of the short-circuit current (Isc) in confluent filter-grown monolayers was strongly reduced by iodide in the apical perfusate. Iodide also increased the fractional resistance of the apical membrane and repolarized the membrane potential, indicating an inhibitory action on the forskolin-induced increase of the apical chloride conductance.(ABSTRACT TRUNCATED AT 250 WORDS)
Bajnath
R B
RB
Department of Experimental Zoology, University of Amsterdam, The Netherlands.
Groot
J A
JA
De Jonge
H R
HR
Kansen
M
M
Bijman
J
J
D000838:Anions; D018118:Chloride Channels / Q000187:drug effects* / Q000502:physiology; D002712:Chlorides / Q000494:pharmacology; D005576:Colforsin / Q000494:pharmacology*; D003110:Colonic Neoplasms / Q000503:physiopathology*; D000242:Cyclic AMP / Q000378:metabolism / Q000494:pharmacology; D004357:Drug Synergism; D004553:Electric Conductivity; D005942:Gluconates / Q000494:pharmacology; D006801:Humans; D007454:Iodides / Q000494:pharmacology; D008564:Membrane Potentials; D015240:Phorbol 12,13-Dibutyrate / Q000494:pharmacology*; D011493:Protein Kinase C / Q000378:metabolism; D011494:Protein Kinases / Q000378:metabolism; D014407:Tumor Cells, Cultured
D000838:Anions; D018118:Chloride Channels; D002712:Chlorides; D005942:Gluconates; D007454:Iodides; D005576:Colforsin; D015240:Phorbol 12,13-Dibutyrate; D000242:Cyclic AMP; D011494:Protein Kinases; D011493:Protein Kinase C; C030691:gluconic acid